Danaher | DHR - Gross Profit On Sales

Stock Price
198.15
Daily Change
-0.46 -0.23%
Monthly
3.53%
Yearly
3.93%
Q2 Forecast
184.43

Danaher reported $3.97B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Abbott USD 6.54B 625M Dec/2025
Agilent USD 946M 44M Dec/2025
Align Technology USD 683.59M 44.39M Dec/2025
Becton, Dickinson and Co. USD 2.41B 1.72B Dec/2025
Bio Techne USD 191.28M 3.16M Dec/2025
Bio-Rad Laboratories USD 343.4M 1.9M Sep/2025
Boston Scientific USD 3.68B 136M Dec/2025
Bruker USD 449.2M 69.8M Dec/2025
Charles River Laboratories USD 271.96M 39.43M Dec/2025
Danaher USD 3.97B 443M Dec/2025
Dentsply International USD 443M 2M Dec/2025
Edwards Lifesciences USD 1.23B 18.7M Dec/2025
ESCO Technologies USD 99.6M 49.54M Dec/2025
Fortive USD 708.9M 59.7M Dec/2025
Henry Schein USD 1.06B 37M Dec/2025
Illumina USD 759M 26M Dec/2025
Intuitive Surgical USD 1.9B 241.9M Dec/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
Keysight Technologies USD 995M 126M Dec/2025
Laboratory Of America USD 993.2M 31.9M Dec/2025
Medtronic USD 5.41B 27M Dec/2025
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Myriad Genetics USD 146.8M 3M Dec/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Quest Diagnostics USD 873M 37M Dec/2025
Quidel USD 274.8M 1.01B Dec/2025
Repligen USD 103.83M 3.32M Dec/2025
Revvity USD 421.66M 47.06M Dec/2025
Roper Industries USD 1.43B 26.9M Dec/2025
Stryker USD 4.49B 633M Dec/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
Waters USD 557.42M 97.44M Dec/2025
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025